ItalianoVILELLA, ANTONIETTA
Dettaglio
VILELLA, ANTONIETTA
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
Pubblicazioni
Risultati 1 - 20 di 37 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Activity and circadian rhythm influence synaptic Shank3 protein levels in mice | 2016 | Sarowar, Tasnuva; Chhabra, Resham; Vilella, Antonietta; Boeckers, Tobias M.; Zoli, Michele; Grabrucker, Andreas M. |
| 2 | Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10 | 2015 | Almolda, Beatriz; de Labra, Carmen; Barrera, Iliana; Gruart, Agnès; Delgado-Garcia, Jose M.; Villacampa, Nàdia; Vilella, Antonietta; Hofer, Markus J.; Hidalgo, Juan; Campbell, Iain L.; González, Berta; Castellano, Bernardo |
| 3 | Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo | 2015 | Chhabra, Resham; Ruozi, Barbara; Vilella, Antonietta; Belletti, Daniela; Mangus, Katharina; Pfaender, Stefanie; Sarowar, Tasnuva; Boeckers, Tobias Maria; Zoli, Michele; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni; Grabrucker, Andreas Martin |
| 4 | Astrocyte-targeted production of IL-10 induces changes in microglial reactivity and reduces motor neuron death after facial nerve axotomy | 2015 | Villacampa, Nàdia; Almolda, Beatriz; Vilella, Antonietta; Campbell, Iain L.; González, Berta; Castellano, Bernardo |
| 5 | Brain targeting by engineered nanoparticles | 2011 | Tosi, Giovanni; A., Grabrucker; L., Bondioli; Ruozi, Barbara; Zoli, Michele; Vilella, Antonietta; Forni, Flavio; Rivasi, Francesco; Vandelli, Maria Angela |
| 6 | Brain targeting by engineered nanoparticles: in vivo and in vitro evidences | 2011 | Tosi, Giovanni; A., Grabrucker; L., Bondioli; Ruozi, Barbara; Zoli, Michele; Vilella, Antonietta; Forni, Flavio; Rivasi, Francesco; Vandelli, Maria Angela |
| 7 | Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. | 2013 | Tosi, Giovanni; Ruozi, Barbara; Belletti, Daniela; Vilella, Antonietta; Zoli, Michele; Vandelli, Maria Angela; Forni, Flavio |
| 8 | DAT atypical inhibitors as novel antipsychotic drugs | 2019 | Daini, Eleonora; Linciano, Pasquale; Sorbi, Claudia; Grilli, Massimo; Zoli, Michele; Franchini, Silvia; Vilella, Antonietta |
| 9 | Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD | 2018 | Palazzoli, Federica; Citti, Cinzia; Licata, Manuela; Vilella, Antonietta; Manca, Letizia; Zoli, Michele; Vandelli, Maria Angela; Forni, Flavio; Cannazza, Giuseppe |
| 10 | Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice | 2019 | Hagmeyer, S; Romão, M. A.; Cristóvão, J. S.; Vilella, A.; Zoli, M.; Gomes, C. M.; Grabrucker A., M |
| 11 | Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior | 2021 | Detraux, B.; Vilella, A.; De Groote, A.; Schiffmann, S. N.; Zoli, M.; de Kerchove d'Exaerde, A. |
| 12 | Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles | 2015 | Vilella, Antonietta; Ruozi, Barbara; Belletti, Daniela; Pederzoli, Francesca; Galliani, Marianna; Semeghini, Valentina; Forni, Flavio; Zoli, Michele; Vandelli, Maria Angela; Tosi, Giovanni |
| 13 | Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments | 2015 | Tosi, Giovanni; Vilella, Antonietta; Veratti, P; Belletti, Daniela; Pederzoli, F; Ruozi, Barbara; Vandelli, Maria Angela; Zoli, Michele; Forni, Flavio |
| 14 | Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors | 2016 | Mapelli, Jonathan; Gandolfi, Daniela; Vilella, Antonietta; Zoli, Michele; Bigiani, Albertino |
| 15 | In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin | 2017 | Barloscio, Davide; Cerri, Elisa; Domenici, Luciano; Longhi, Renato; Dallanoce, Clelia; Moretti, Milena; Vilella, Antonietta; Zoli, Michele; Gotti, Cecilia; Origlia, Nicola |
| 16 | Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution | 2014 | VILELLA, ANTONIETTA; TOSI, Giovanni; Andreas M., Grabrucker; RUOZI, Barbara; BELLETTI, Daniela; VANDELLI, Maria Angela; Tobias M., Boeckers; FORNI, Flavio; ZOLI, Michele |
| 17 | Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport | 2014 | Tosi, Giovanni; Vilella, Antonietta; Resham, Chhabra; Michael J., Schmeisser; Tobias M., Boeckers; Ruozi, Barbara; Vandelli, Maria Angela; Forni, Flavio; Zoli, Michele; Andreas M., Grabrucker |
| 18 | LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response | 2018 | Rigillo, Giovanna; Vilella, Antonietta; Benatti, Cristina; Schaeffer, Laurent; Brunello, Nicoletta; Blom, Johanna M. C.; Zoli, Michele; Tascedda, Fabio |
| 19 | Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery | 2012 | Tosi, Giovanni; Ruozi, Barbara; Vilella, Antonietta; Belletti, Daniela; Veratti, Patrizia; Baraldi, Elisa; Zoli, Michele; M., Schmeisser; A., Grabrucker; Forni, Flavio; Vandelli, Maria Angela; A., Sharma; H. S., Sharma |
| 20 | Nanomedicine in neurodegenerative disorders: Understanding the journey | 2015 | Tosi, G.; Ruozi, B.; Vilella, A.; Grabrucker, A. M.; Belletti, D.; Vandelli, M. A.; Boeckers, T. M.; Forni, F.; Zoli, M.; Sharma, A.; Muresanu, D. F.; Sharma, H. S. |
Copyright © 2022